BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10894068)

  • 1. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
    Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
    Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections.
    Abujudeh HH; Kosaraju VK; Kaewlai R
    AJR Am J Roentgenol; 2010 Feb; 194(2):430-4. PubMed ID: 20093606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse reactions to gadolinium contrast media: a review of 36 cases.
    Murphy KJ; Brunberg JA; Cohan RH
    AJR Am J Roentgenol; 1996 Oct; 167(4):847-9. PubMed ID: 8819369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse allergic reactions to linear ionic gadolinium-based contrast agents: experience with 194, 400 injections.
    Aran S; Shaqdan KW; Abujudeh HH
    Clin Radiol; 2015 May; 70(5):466-75. PubMed ID: 25626627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical safety of gadopentetate dimeglumine.
    Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA
    Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reaction to intravenous gadoteridol.
    Shellock FG; Hahn HP; Mink JH; Itskovich E
    Radiology; 1993 Oct; 189(1):151-2. PubMed ID: 8372186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
    McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
    Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults.
    Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
    AJR Am J Roentgenol; 2007 Dec; 189(6):1533-8. PubMed ID: 18029897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and severity of acute adverse reactions to four different gadolinium-based MR contrast agents.
    Okigawa T; Utsunomiya D; Tajiri S; Okumura S; Sasao A; Wada H; Oda S; Arimura H; Hayashida E; Urata J; Yamashita Y
    Magn Reson Med Sci; 2014; 13(1):1-6. PubMed ID: 24492735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication.
    Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
    AJR Am J Roentgenol; 2008 Jan; 190(1):187-90. PubMed ID: 18094310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is a mixture of gadolinium and iodinated contrast material safe during MR arthrography?
    Brown RR; Clarke DW; Daffner RH
    AJR Am J Roentgenol; 2000 Oct; 175(4):1087-90. PubMed ID: 11000170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in adverse events after IV administration of contrast media.
    Cochran ST; Bomyea K; Sayre JW
    AJR Am J Roentgenol; 2001 Jun; 176(6):1385-8. PubMed ID: 11373197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
    Myhr G; Rinck PA; Børseth A
    Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate hypersensitivity reaction to gadolinium-based MR contrast media.
    Jung JW; Kang HR; Kim MH; Lee W; Min KU; Han MH; Cho SH
    Radiology; 2012 Aug; 264(2):414-22. PubMed ID: 22550309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe adverse reactions with contrast agents for magnetic resonance: clinical experience in 30,000 MR examinations.
    De Ridder F; De Maeseneer M; Stadnik T; Luypaert R; Osteaux M
    JBR-BTR; 2001 Aug; 84(4):150-2. PubMed ID: 11688727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates.
    Li A; Wong CS; Wong MK; Lee CM; Au Yeung MC
    Br J Radiol; 2006 May; 79(941):368-71. PubMed ID: 16632615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].
    Heuck A; Reiser M
    Internist (Berl); 1997 Dec; 38(12):1234-5. PubMed ID: 9465330
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency and Severity of Acute Allergic-Like Reactions to Intravenously Administered Gadolinium-Based Contrast Media in Children.
    Forbes-Amrhein MM; Dillman JR; Trout AT; Koch BL; Dickerson JM; Giordano RM; Towbin AJ
    Invest Radiol; 2018 May; 53(5):313-318. PubMed ID: 29337841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging contrast agents.
    Runge VM
    Curr Opin Radiol; 1992 Feb; 4(1):3-12. PubMed ID: 1739599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.